We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial, CSL Behring, CON-1249
Product name
CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial
Sponsor name
CSL Behring
Consent start
Consent no.
CON-1249
Duration
The consent is effective from 5 April 2024 until 1 October 2031.
Standard
Part 2 Subsection 10(4) Schedule 1 Item 10 (c) – Period of ineligibility (a) or (b) or (c). of Therapeutic Goods (Standard for Human Cell and Tissue Products - Donor Selection Requirements) (TGO 108) Order 2021
Non-compliance with standard
People who have a tattoo performed at a licensed/registered tattoo parlour or
cosmetic clinic in Australia can be accepted as a donor for plasma for
fractionation only with no deferral period from the time of the last tattoo
procedure.
Import, Supply, &/or Export
supply
Therapeutic product type
Prescription medicines